Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Natasha Rekhtman's publication output changed over time?
ScholarIQpublication output · 2015–2018
Output grew0% over the shown period — from 1 works in 2015 to 1 in 2018.
1
1
20152018
What are the most-cited papers on Natasha Rekhtman?
ScholarIQmost cited works
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Naiyer A. Rizvi, Matthew D. Hellmann, Alexandra Snyder, Pia Kvistborg, Vladimir Makarov, Jonathan J. Havel, William Lee, Jianda Yuan, Phillip Wong, Teresa Ho, Martin L. Miller, Natasha Rekhtman, André L. Moreira, Fawzia K. Ibrahim, Cameron Bruggeman, Billel Gasmi, Roberta Zappasodi, Yuka Maeda, Chris Sander, Edward B. Garon, Taha Merghoub, Jedd D. Wolchok, Ton N. Schumacher, Timothy A. Chan
Science. 20157,986 Citations
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
Patrick M. Forde, Jamie E. Chaft, Kellie N. Smith, Valsamo Anagnostou, Tricia R. Cottrell, Matthew D. Hellmann, Marianna Zahurak, Stephen C. Yang, David R. Jones, Stephen Broderick, Richard J. Battafarano, Moises J. Velez, Natasha Rekhtman, Zachary T. Olah, Jarushka Naidoo, Kristen A. Marrone, Franco Verde, Haidan Guo, Jiajia Zhang, Justina X. Caushi, Hok Yee Chan, John-William Sidhom, Robert B. Scharpf, James R. White, Edward Gabrielson, Hao Wang, Gary L. Rosner, Valerie W. Rusch, Jedd D. Wolchok, Taha Merghoub, Janis M. Taube, Victor E. Velculescu, Suzanne L. Topalian, Julie R. Brahmer, Drew M. Pardoll
New England Journal of Medicine. 20182,149 CitationsOPEN ACCESS
Related on ScholarIQ
Memorial Sloan Kettering Cancer Center
University
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Paper
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
Paper
Cancer Genomics and Diagnostics
Topic
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Research Studies
Topic